Customized solutions, better diagnostics

Diagnotix introduces the thrid psychotropic medication panel for antidepressants

Back to overview Back to overview
News

Diagnotix introduces the thrid psychotropic medication panel for antidepressants

Written: 22 January 2025

Diagnotix Expands TDM Solutions with New PS 3 Panel for Antidepressants

Diagnotix proudly announces the introduction of its third panel for therapeutic drug monitoring (TDM) analyses by LC-MS. Complementing the existing PS 1 panel for tricyclic antidepressants and the PS 2 panel for neuroleptics, the new PS 3 panel focuses on other commonly used antidepressants.

The PS 3 panel includes the following analytes:

Citalopram
Norcitalopram
Fluoxetine
Norfluoxetine
Fluvoxamine
Mirtazapine
Normirtazapine
Paroxetine
Sertraline
Norsertraline
Venlafaxine
Norvenlafaxine


With the addition of PS 3, Diagnotix now offers solutions for over 95% of the most commonly prescribed psychotropic medications, ensuring comprehensive TDM coverage.

Optimized Design for Maximum Efficiency

Our panels have been carefully designed to balance a broad range of analytes with cost-efficiency. Smaller, focused panels provide distinct advantages:

Reduced Costs:
Lower expenses for internal standards of rare compounds.
Improved Chromatographic Performance:
Better optimization of chromatography conditions.

To maximize the capabilities of your advanced LC-MS system, each panel includes tailored mobile phases and a dedicated column, instead of a one-size-fits-all approach. This ensures superior performance and allows you to fully benefit from the technological potential of your equipment.

Diagnotix remains committed to providing innovative and reliable solutions for LC-MS-based TDM analyses. Contact us today to learn more about our panels and how they can support your laboratory's needs.

Information about the PS 3 LC-MS Kit Information about the PS3 Calibrator set Information about the PS3 Control set
Also of interest
Interested in our products or services?
Contact us
or call us on +31 (0)596 20 10 62